drugset / Trial / NCT05625373

The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection

NCT05625373

Phase 2/3 Recruiting 30 enrolled Women and Infants Hospital of Rhode Island
RandomizedParallel-groupOpen-labelPrevention

Summary

The study will be a pilot randomized control trial with a 1:1 patient randomization of vancomycin powder placement at the time of surgery (compared to no vancomycin placement) with the goal of reducing postoperative complications in patients undergoing an inguinal lymph node dissection for vulvar cancer. The primary objective is to measure the composite rate of postoperative complications within 30 days of inguinal lymph node dissection in patients with vulvar cancer.

Timeline

Start
2022-10-25
Primary completion
2024-04-25
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified 1 g Other

Indications

No indication recorded.